Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing rocuronium and cisatracurium in patients with chronic kidney disease to assess risk of acute complications; currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cisatracurium (Cisatracurium besylate)
  • Rocuronium (rocuronium bromide)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Post Operative Pulmonary Complications, Neuromuscular Blockade | Phase 4 | Status: RECRUITING